Premium
Multiple private equity players including Apax Partners, TPG Capital, TA Associates and Kedaara Capital are in early talks to buy a Mumbai-based pharma company that makes oral dosage formulations on contract manufacturing basis, a media report has said. The investors are looking to acquire Inventia Healthcare at a valuation of Rs ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
